Ignacio Zarante

Ignacio Zarante

Auto-generated profile, based on publicly available information

Ignacio Zarante

Faculty of Medicine, Human Genetics Institute, Pontificia Universidad Javeriana, Bogotá, D.C, Colombia

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 November 2023 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
MGMichael A Gargano
Michael A Gargano
NMNicolas Matentzoglu
Nicolas Matentzoglu
BCBen Coleman
Ben Coleman
EAEunice B Addo-Lartey
Eunice B Addo-Lartey
AAAnna V Anagnostopoulos
Anna V Anagnostopoulos
PRPeter N. Robinson
Peter N. Robinson
The Human Phenotype Ontology (HPO) is a widely used resource that comprehensively organizes and defines the phenotypic features of human disease, enabling computational inference and supporting genomic and phenotypic analyses through semantic similarity and machine learning algorithms. The HPO has widespread applications in clinical diagnostics and translational research, including genomic diagnostics, gene-disease discovery, and cohort analytics. In recent years, groups around the world have developed translations of the HPO from English to other languages, and the HPO browser has been internationalized, allowing users to view HPO term labels and in many cases synonyms and definitions in ten languages in addition to English. Since our last report, a total of 2239 new HPO terms and 49235 new HPO annotations were developed, many in collaboration with external groups in the fields of psychiatry, arthrogryposis, immunology and cardiology. The Medical Action Ontology (MAxO) is a new effort to model treatments and other measures taken for clinical management. Finally, the HPO consortium is contributing to efforts to integrate the HPO and the GA4GH Phenopacket Schema into electronic health records (EHRs) with the goal of more standardized and computable integration of rare disease data in EHRs.

9 July 2019 in European Urology
Verified
Journal Article
Closed access
XYXiao Yu
Xiao Yu
NNNatasha Nassar
Natasha Nassar
PMPierpaolo Mastroiacovo
Pierpaolo Mastroiacovo
MCMark Canfield
Mark Canfield
BGBoris Groisman
Boris Groisman
AAA.J. Agopian
A.J. Agopian

1 April 2021 in Annals of Epidemiology
Verified
Journal Article
Closed access
MPMaria Politis
Maria Politis
EBEva Bermejo-Sánchez
Eva Bermejo-Sánchez
MCMark A. Canfield
Mark A. Canfield
PCPaolo Contiero
Paolo Contiero
JCJanet D. Cragan
Janet D. Cragan
WNWendy N. Nembhard
Wendy N. Nembhard

30 September 2019 in American Journal of Medical Genetics Part A
Verified
Journal Article
Closed access
PDF file
NGNitin Goel
Nitin Goel
JMJoan K. Morris
Joan K. Morris
DTDavid Tucker
David Tucker
HWHermien E. K. de Walle
Hermien E. K. de Walle
MBMarian K. Bakker
Marian K. Bakker
MMMargery Morgan
Margery Morgan

3 August 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
ATAndrew T. Timberlake
Andrew T. Timberlake
CGCasey Griffin
Casey Griffin
CHCarrie L. Heike
Carrie L. Heike
AHAnne V. Hing
Anne V. Hing
MCMichael L. Cunningham
Michael L. Cunningham
DLDaniela V. Luquetti
Daniela V. Luquetti
Craniofacial microsomia (CFM) is the second most common congenital facial anomaly, yet its genetic etiology remains unknown. We perform whole-exome or genome sequencing of 146 kindreds with sporadic (n = 138) or familial (n = 8) CFM, identifying a highly significant burden of loss of function variants in SF3B2 (P = 3.8 × 10−10), a component of the U2 small nuclear ribonucleoprotein complex, in probands. We describe twenty individuals from seven kindreds harboring de novo or transmitted haploinsufficient variants in SF3B2. Probands display mandibular hypoplasia, microtia, facial and preauricular tags, epibulbar dermoids, lateral oral clefts in addition to skeletal and cardiac abnormalities. Targeted morpholino knockdown of SF3B2 in Xenopus results in disruption of cranial neural crest precursor formation and subsequent craniofacial cartilage defects, supporting a link between spliceosome mutations and impaired neural crest development in congenital craniofacial disease. The results establish haploinsufficient variants in SF3B2 as the most prevalent genetic cause of CFM, explaining ~3% of sporadic and ~25% of familial cases.

1 March 2010 in Biomédica
Verified
Journal Article
Open access
PDF file
IZIgnacio Zarante
Ignacio Zarante
LFLiliana Franco
Liliana Franco
CLCatalina López
Catalina López
NFNicolás Fernández
Nicolás Fernández
Frecuencia de malformaciones congénitas: evaluación y pronóstico de 52.744 nacimientos en tres ciudades colombianas